[{"Assets_0_FY_USD":1713416000.0,"StockholdersEquityConverted_0_FY_USD":-53842000.0,"StockholdersEquity_0_FY_USD":-54106000.0,"RevenuesConverted_1_FY_USD":506121000.0,"RevenuesConverted_4_FY_USD":1176115000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":89567000.0,"NetIncomeLossConverted_1_FY_USD":38257000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":373276000.0,"EarningsPerShareDiluted_4_FY_USD":2.94,"EarningsPerShareDiluted_1_FY_USD":0.43,"EarningsPerShareBasic_4_FY_USD":3.0,"EarningsPerShareBasic_1_FY_USD":0.44,"CommonStockSharesConverted_0_FY_shares":104275000.0,"NetIncomeLossConverted_4_FY_USD":263144000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":87769000.0,"Ticker":"IDXX","CIK":"874716","name":"IDEXX LABORATORIES INC \/DE","OfficialName":"IDEXX Laboratories Inc. Common Stock","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"42180715521.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"SP500","filed":"20180216"}]